AstraZeneca PLC is 109.4x more valuable than SUPERNUS PHARMACEUTICALS, INC. by market capitalization ($286.27 B vs $2.62 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SUPN | AZN |
|---|---|---|
| Market cap | $2.62 B | $286.27 B |
| US-listed rank | #1908 | #45 |
| Revenue (latest FY) | $718.95M | - |
| Net income (latest FY) | -$38.60M | - |
| Net margin | -5.4% | - |
| SEC filings | 1,154 | 1,004 |
AstraZeneca PLC is 109.4x more valuable than SUPERNUS PHARMACEUTICALS, INC. by market capitalization ($286.27 B vs $2.62 B).
Full pages: SUPERNUS PHARMACEUTICALS, INC. and AstraZeneca PLC, or browse the full rankings.